PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
October 1, 2019Molecular Case StudiesOpen Access

Novel PDGFRB rearrangement in multifocal infantile myofibromatosis is tumorigenic and sensitive to imatinib

View Full Paper
Ask AI
Bookmark
Share

Authors

MHMohammed HassanEBErin ButlerRWRaphael A. Wilson

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Hassan et al. (2019) studied this question.

synapsesocial.com/papers/6aa69446b3a9aaf5308e48b0https://doi.org/10.1101/mcs.a004440
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice.1994 · 997 citations
  2. 2Pharmacokinetics and Pharmacodynamics of Imatinib in a Phase I Trial With Chronic Myeloid Leukemia Patients2004 · 470 citations
  3. 3G 1 Events and Regulation of Cell Proliferation1989 · 2,206 citations
  4. 4Vincristine and Dactinomycin in Infantile Myofibromatosis With a Review of Treatment Options2014 · 29 citations
  5. 5Fibroblastic and myofibroblastic tumors of children: new genetic entities and new ancillary testing2018 · 16 citations